✦ LIBER ✦

Gemcitabine at fixed dose-rate in patients with advanced soft tissue sarcomas: a mono-institutional phase II study

✍ Scribed by Virginia Ferraresi; Mariangela Ciccarese; Maria Cecilia Cercato; Carmen Nuzzo; Massimo Zeuli; Franco Di Filippo; Diana Giannarelli; Francesco Cognetti

Publisher: Springer
Year: 2008
Tongue: English
Weight: 304 KB
Volume: 63
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-008-0723-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of weekly docetaxel and f

Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma

✍ Eun Mi Lee; Sun Young Rha; Jeeyun Lee; Kyong Hwa Park; Jin-Hee Ahn 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 224 KB

Phase II study with the combination of g

Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas

✍ R. Losa; J. Fra; A. López-Pousa; M. Sierra; A. Goitia; E. Uña; R. Nadal; J. Garc 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 402 KB

Oral piritrexim — A phase II study in pa

Oral piritrexim — A phase II study in patients with advanced soft tissue sarcoma

✍ Judith D. Schiesel; Matthew Carabasi; Gordon Magill; Ephraim Casper; Edgar Cheng 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 129 KB

Gemcitabine and vinorelbine combination

Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas : Results of a phase II trial

✍ Palma Dileo; Jeffrey A. Morgan; David Zahrieh; Jayesh Desai; Jeanine M. Salesi; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

## Abstract ## BACKGROUND. Single‐agent gemcitabine and vinorelbine have activity in treatment of patients with soft‐tissue sarcomas. The combination of gemcitabine plus vinorelbine has activity against several forms of metastatic carcinoma with acceptable toxicity. This study evaluated the effica

Phase I clinical trial of fixed–dose rat

Phase I clinical trial of fixed–dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation

✍ José M. Buesa; Raquel Losa; Aida Fernández; Marta Sierra; Emilio Esteban; Ángela 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Phase I dose-escalating study of biweekl

Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors

✍ Yuan Yuan; Deirdre J. Cohen; Erica Love; Michelle Yaw; Benjamin Levinson; Steven 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 289 KB